Menin Inhibitor BMF-219 – Talk Bio

Actionable Insights Powered by AI

Biomea’s Early-Stage Diabetes Drug Placed on Full Clinical Hold, Stock Plummets

11 months ago talkbio0Tagged Biomea, crash, Diabetes, Liver, Menin Inhibitor BMF-219, Study on Hold, Toxicity aspects, United States Food and Drug Administration

Biomea, diabetes, clinical hold, FDA, BMF-219, liver toxicity, stock crash